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Angiomatoid fibrous histiocytoma (AFH) is a rarely metastasizing soft tissue tumor of uncertain differentiation. It accounts for only about 0.3% of all 
soft tissue tumors [1,2]. Most of the patients present in the first 
3 decades of life; however, cases occurring in wide age range 
have been reported. There is no significant sex predilection. It 
frequently occurs superficially in the deep dermis and subcutis of 
the extremities as a slowly growing, superficial nodular mass [3]. 
Some patients experience systemic symptoms such as pyrexia, 
anemia, and malaise due to tumoral cytokine production [4]. 
Clinically and radiographically, the lesion is easily confused 
with a hematoma, soft tissue hemangioma, or malignant fibrous 
histiocytoma. Making a pre-operative diagnosis of AFH is 
challenging with no distinct clinical or imaging findings to lead 
to a diagnosis. Correct diagnosis is important because of the small 
risk of metastasis and death.
When Enzinger initially described “angiomatoid malignant 
fibrous histiocytoma” in 1979, the histogenesis was controversial. 
Today, the precise line of differentiation remains unknown, but 
this entity is no longer termed “malignant” due to its benign 
microscopic appearance and favorable prognosis. The 2002 World 
Health Organization classification removed it from the malignant 
fibrous histiocytoma subtype of sarcoma (now synonymous 
with undifferentiated pleomorphic sarcoma) and classified it as 
tumors of uncertain differentiation as AFH [5]. Here, we present 
a case report of this rare tumor in unusual age group (elderly 
male) which had a provisional clinico-radiological diagnosis of 
sarcoma. Moreover, very focal lymphoplasmacytic inflammatory 
infiltrate made diagnosis a challenge in the present case.
CASE REPORT
A 67-year-old male presented with a left thigh swelling for past 
the 3 years which was gradually increasing in size. Swelling 
was painless to start with, but the patient developed dull aching, 
continuous pain for the past 1 year. There were no complaints 
of fever, malaise, or weight loss. On examination, there was a 
20×16 cm soft, fluctuating, mildly tender swelling over lateral 
compartment of left thigh. Laboratory studies revealed anemia 
with hemoglobin of 10.3 g/dL (reference 13.5–17.5 g/dL). 
His erythrocyte sedimentation rate was 45 mm in 1 h (normal 
0–22 mm in 1 hour). Magnetic resonance imaging (MRI) 
revealed a 19.9×14×11 cm mixed solid cystic multiloculated, 
heterogeneously enhancing mass with internal hemorrhage in 
the subcutaneous left lateral proximal thigh. No evidence of 
underlying muscle invasion was evident. Clinico-radiological 
diagnosis of sarcoma was made.
Repeated Fine needle aspiration attempts revealed degenerated 
cells alongwith a blood mixed mucoid material and no presumptive 
diagnosis could be made.  Punch biopsy revealed only adipose 
and fibrocollagenous tissue and further led to diagnostic dilemma. 
Surgical excision of the entire tumor  alongwith involved fascia 
lata was done with a provisional clinico-radiological diagnosis 
of sarcoma. Tumor was 10×9×6 cm in size, solid-cystic, firm, 
lobulated, multinodular with myxoid, necrotic, and hemorrhagic 
areas (Fig. 1a). Cystic areas were filled with blood. Periphery of 
the tumor was gray-white firm. Overlying skin was thinned out. 
Microscopic examination revealed variably sized blood-filled 
cystic spaces surrounded by sheets of histiocytes with bland, 
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vesicular nuclei with few showing mild nuclear atypia along with 
hemosiderin-laden macrophages and giant cells (Fig. 1b and c). 
Few spindle-shaped cells and occasional cells with more abundant 
cytoplasm (rhabdomyoblast like cells) (Fig. 1d). However, no 
striations were seen and thus initial provisional diagnosis of 
rhabdomyosarcoma was excluded. Surrounding these blood-
filled cystic spaces was a fibrous pseudocapsule. We did not get 
much lymphoplasmacytic infiltrate initially. Only after extensive 
sectioning, focal area of lymphoplasmacytic infiltrate was found 
(Fig. 1c). Areas of necrosis and calcification were also seen. 
Immunohistochemistry (IHC) showed strong positivity for CD68 
in the histiocytes lining the pseudo vascular spaces, variable 
positivity for CD34 (Fig. 1f), desmin, epithelial membrane 
antigen (EMA), negativity for cytokeratin, and low Ki67 index 
of 2% (Fig. 1d and e). Diagnosis of AFH was made based on 
histopathology and immunohistochemistry.
DISCUSSION
AFH was first described in 1979 [6]. It typically occurs in 
the extremities of children and young adults as a slowly growing, 
superficial nodular mass; although wide age range has also been 
reported [7]. AFH in elderly is very rare with very few cases 
reports could be found after an extensive review of literature. 
The majority of cases occur in the extremities; although cases 
have been reported in the head and neck region (10%) and 
trunk. The tumor is rare, accounting for approximately 0.3% 
of all soft tissue neoplasms. It is likely to have been previously 
underdiagnosed and placed under other neoplastic categories 
(vascular, fibrohistiocytic, and myofibroblastic types).
Making a pre-operative diagnosis of AFH is difficult. Imaging 
studies alone cannot differentiate AFH from sarcoma. Although 
nonspecific, a mass with MRI findings of cystic areas, enhancing 
fibrous pseudo capsule, and internal areas of hemorrhage in the 
extremity of a child or adolescent should prompt the differential 
of AFH. However, some cases may show predominantly solid 
areas. Wide surgical excision and post-excisional monitoring are 
essential.
The diagnosis of AFH is based on histopathology and IHC. 
Macroscopically, AFH is generally firm and circumscribed. The 
characteristic microscopic appearance includes a fibrous pseudo 
capsule, pseudoangiomatous cystic spaces surrounded by round 
to spindle fibrohistiocytic cells with bland, vesicular nuclei, and a 
plasma lymphocytic infiltrate [7,8]. IHC shows variable positivity 
for desmin, CD68, and CD99 [9].
The differential diagnosis of AFH is wide-ranging from benign 
granulomas to malignant neoplasms. AFH of long duration can 
mimic hematoma due to extensive fibrosis, hemorrhage, and 
hemosiderin deposition. Granulomatous inflammation can be 
differentiated due to lack of vascular spaces in them and more 
solid appearance of AFH. Spindle cell hemangioma is poorly 
circumscribed with true vascular spaces as compared to fairly 
circumscribed pseudoangiomatous lesion, AFH. Nodular Kaposi 
sarcoma presents as a circumscribed dermal lesion with bland 
cytology containing slit like blood-filled spaces unlike the blood-
filled cysts are seen in AFH. Rhabdomyosarcoma is situated 
Figure 1: (a) Gross finding-showing solid cystic cut surface with blood filled cystic space, (b) H and E 4× - Showing many blood-filled pseudo 
vascular channels, (c) H and E 10× - Showing very focal lymphocytic inflammatory infiltrate (black arrow), (d) H and E 40× - Showing 
spindle shaped cells along with hemosiderin-laden macrophages (black arrow), (e) immunohistochemistry (IHC) - CD68 positive histiocytes 
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deeply and is infiltrative without a peripheral lymphoid cuff when 
compared with AFHs.
About 80% cases of AFH show dense lymphoplasmacytic 
infiltrate, unlike our case which showed only focal infiltrate after 
extensive sampling. Thus, the only constant finding of AFH is the 
presence of sheets of oval to spindled cells, and features such as 
fibrous capsule or lymphoplasmacytic infiltrate may be absent or 
not sampled [8].
As AFH lacks a specific immunophenotypic, IHC is 
supportive and not diagnostic. There is variable immunoreactivity 
for the EMA, desmin, CD68, smooth muscle actin, calponin, 
and CD99 [9]. Molecular studies are most helpful for 
confirming a diagnosis of angiomatoid fibrous histiocytoma 
but was not available in our case. Distinctive chromosomal 
translocations are found angiomatoid fibrous histiocytoma, with 
EWS/CREB1(CAMP responsive element binding protein 1) 
fusion being the most common (>75% of cases), others being 
EWS/ATF1 and FUS/ATF.
Most AFHs have a benign course with local recurrence 
seen in up to 15% of cases and <5% cases showing metastasis, 
predominantly to regional lymph nodes followed by lungs, 
liver, or brain [6]. However, deaths from distant metastases 
have rarely occurred. Appropriate management is wide local 
excision with follow-up as it has a small risk of metastasis and 
death. Adjuvant radiotherapy or chemotherapy may be required 
in unrespectable cases and those showing metastasis. Our 
case has been followed up and found to be disease-free after 
10 months of surgery. No chemo or radiotherapy was given to 
the patient.
CONCLUSIONS
AFH is a rare disease that is often misdiagnosed initially due 
to its wide variation in morphology, site of occurrence and bland 
morphology. AFH can recur locally, but most of these patients do 
well with wide local excisions alone. Histopathology and IHC 
findings point toward diagnosis of AFH, however, molecular 
studies can only lead to confirmation. Correct diagnosis and close 
clinical follow-up of AFH patient is important as it has a small 
risk of metastasis and death.
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